Moritz Binder

2.8k total citations
76 papers, 909 citations indexed

About

Moritz Binder is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Moritz Binder has authored 76 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Hematology, 28 papers in Molecular Biology and 24 papers in Oncology. Recurrent topics in Moritz Binder's work include Multiple Myeloma Research and Treatments (26 papers), Protein Degradation and Inhibitors (13 papers) and Acute Myeloid Leukemia Research (12 papers). Moritz Binder is often cited by papers focused on Multiple Myeloma Research and Treatments (26 papers), Protein Degradation and Inhibitors (13 papers) and Acute Myeloid Leukemia Research (12 papers). Moritz Binder collaborates with scholars based in United States, Germany and United Kingdom. Moritz Binder's co-authors include Ronald L. Koretz, Eric A. Strom, Richard A.L. Sturdevant, Rosa Camacho, Arthur D. Schwabe, Robert Cano, Jorge E. Valenzuela, Arnaldo Ippoliti, Jon I. Isenberg and Carisa M. Cooney and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Moritz Binder

64 papers receiving 843 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Moritz Binder United States 19 396 325 182 165 143 76 909
Nataša Čolović Serbia 17 344 0.9× 210 0.6× 138 0.8× 202 1.2× 161 1.1× 119 908
Rainer Hubmann Austria 17 102 0.3× 406 1.2× 231 1.3× 172 1.0× 135 0.9× 61 1.1k
Irina Costea Canada 17 159 0.4× 336 1.0× 147 0.8× 60 0.4× 137 1.0× 23 1.1k
Muhammad Shurafa United States 12 420 1.1× 271 0.8× 89 0.5× 262 1.6× 319 2.2× 29 912
Abraham Kornberg Israel 17 346 0.9× 189 0.6× 105 0.6× 106 0.6× 80 0.6× 54 925
Mansour Alfayez United States 15 410 1.0× 233 0.7× 43 0.2× 158 1.0× 161 1.1× 54 775
Antoni Stadnicki Poland 22 183 0.5× 101 0.3× 172 0.9× 339 2.1× 63 0.4× 43 818
Hawk Kim South Korea 22 882 2.2× 342 1.1× 84 0.5× 340 2.1× 443 3.1× 111 1.5k
Edith Bigot‐Corbel France 15 132 0.3× 170 0.5× 87 0.5× 106 0.6× 85 0.6× 54 575
Carlos Chiattone Brazil 22 551 1.4× 171 0.5× 70 0.4× 503 3.0× 278 1.9× 99 1.1k

Countries citing papers authored by Moritz Binder

Since Specialization
Citations

This map shows the geographic impact of Moritz Binder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moritz Binder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moritz Binder more than expected).

Fields of papers citing papers by Moritz Binder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moritz Binder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moritz Binder. The network helps show where Moritz Binder may publish in the future.

Co-authorship network of co-authors of Moritz Binder

This figure shows the co-authorship network connecting the top 25 collaborators of Moritz Binder. A scholar is included among the top collaborators of Moritz Binder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moritz Binder. Moritz Binder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Binder, Moritz, Joselle Cook, Morie A. Gertz, et al.. (2025). The ratio of brain to liver glucose activity and disease activity in multiple myeloma. Blood Cancer Journal. 15(1). 90–90.
2.
Barreto, Jason N., A. Kosobud, Prashant Kapoor, et al.. (2025). Outpatient Management of Bispecific Related Toxicities: An Observational Study of Safety Outcomes and Resource Utilization. JCO Oncology Practice. 22(1). 83–90. 1 indexed citations
3.
Cook, Joselle, Rahma Warsame, Francis K. Buadi, et al.. (2025). Interleukin-6 is a highly prognostic biomarker for POEMS syndrome. Leukemia. 39(9). 2281–2284.
4.
Binder, Moritz, Joselle Cook, Morie A. Gertz, et al.. (2025). Implications of lymphocyte kinetics after chimeric antigen receptor T cell therapy for multiple myeloma. Leukemia. 39(4). 1005–1008. 1 indexed citations
5.
Zanwar, Saurabh, Martha M. Howe, Moritz Binder, et al.. (2024). The Mutational Landscape of Extramedullary Multiple Myeloma Reveals Novel Biologic Insights and Potential Therapeutic Targets for Exploration. Blood. 144(Supplement 1). 2744–2744. 1 indexed citations
6.
Bansal, Radhika, Hassan B. Alkhateeb, Stephen M. Ansell, et al.. (2024). Metformin and cytokine release syndrome after immune effector cell therapy.. Journal of Clinical Oncology. 42(16_suppl). e14535–e14535.
7.
Abdallah, Nadine, Arjun Lakshman, Shaji Kumar, et al.. (2024). Mode of progression in smoldering multiple myeloma: a study of 406 patients. Blood Cancer Journal. 14(1). 9–9. 10 indexed citations
8.
9.
Visram, Alissa, Suzanne R. Hayman, Angela Dispenzieri, et al.. (2023). A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL). American Journal of Hematology. 98(8). 1277–1285. 1 indexed citations
10.
Yao, Chi‐Yuan, Chien‐Chin Lin, Fabio M. R. Amaral, et al.. (2023). A three‐gene leukaemic stem cell signature score is robustly prognostic in chronic myelomonocytic leukaemia. British Journal of Haematology. 201(2). 302–307. 2 indexed citations
11.
Buadi, Francis K., Suzanne R. Hayman, Shaji Kumar, et al.. (2023). Long-term outcomes of allogeneic stem cell transplant in multiple myeloma. Blood Cancer Journal. 13(1). 126–126. 9 indexed citations
12.
Abdallah, Nadine, Alexandra N. Smith, Susan M. Geyer, et al.. (2023). Conditional survival in multiple myeloma and impact of prognostic factors over time. Blood Cancer Journal. 13(1). 78–78. 12 indexed citations
13.
Ismail, Wazim Mohammed, Amelia Mazzone, Jenna Fernandez, et al.. (2023). Characterization and Optimization of Multiomic Single-Cell Epigenomic Profiling. Genes. 14(6). 1245–1245. 4 indexed citations
14.
Sharma, Neeraj, James B. Smadbeck, Nadine Abdallah, et al.. (2021). The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma. Clinical Cancer Research. 27(19). 5430–5439. 22 indexed citations
15.
Taylor, Justin, Xiaoli Mi, Khrystyna North, et al.. (2020). Single-cell genomics reveals the genetic and molecular bases for escape from mutational epistasis in myeloid neoplasms. Blood. 136(13). 1477–1486. 38 indexed citations
16.
Bezerra, Evandro D., Giacomo Coltro, Terra L. Lasho, et al.. (2020). Landscape of RAS pathway mutations in patients with myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a study of 461 molecularly annotated patients. Leukemia. 35(2). 644–649. 7 indexed citations
17.
Binder, Moritz, S. Vincent Rajkumar, Rhett P. Ketterling, et al.. (2019). Substratification of patients with newly diagnosed standard‐risk multiple myeloma. British Journal of Haematology. 185(2). 254–260. 10 indexed citations
18.
Vallapureddy, Rangit, Terra L. Lasho, Christy M. Finke, et al.. (2019). Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients. American Journal of Hematology. 94(7). 767–779. 49 indexed citations
19.
Coltro, Giacomo, Abhishek A. Mangaonkar, Terra L. Lasho, et al.. (2019). Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)—a study of 1084 patients. Leukemia. 34(5). 1407–1421. 63 indexed citations
20.
Cotter, Thomas G., Moritz Binder, Edward V. Loftus, et al.. (2016). Development of a Microscopic Colitis Disease Activity Index: a prospective cohort study. Gut. 67(3). 441–446. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nataša Čolović Breakdown of academic impact, for papers by Rainer Hubmann Breakdown of academic impact, for papers by Irina Costea Breakdown of academic impact, for papers by Muhammad Shurafa Breakdown of academic impact, for papers by Abraham Kornberg Breakdown of academic impact, for papers by Mansour Alfayez Breakdown of academic impact, for papers by Antoni Stadnicki Breakdown of academic impact, for papers by Hawk Kim Breakdown of academic impact, for papers by Edith Bigot‐Corbel Breakdown of academic impact, for papers by Carlos Chiattone
Rankless by CCL
2026